Keros Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold KROS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

21
Funds holding
$55634889
Total value held
Buying
11 added/new · 9 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $29898120 2794217 +382424 +15.86%
2 Federated Hermes, Inc. $7494569 700427 +700427 NEW BUY
3 State Street Corp $5790765 541193 -20537 -3.66%
4 Goldman Sachs Group Inc $1902953 177846 -46633 -20.77%
5 Wells Fargo & Company/Mn $1663636 155480 +4440 +2.94%
6 Northern Trust Corp $1646121 153843 -100344 -39.48%
7 Ubs Group Ag $1476461 137987 +137987 NEW BUY
8 Bank Of New York Mellon Corp $1105726 103339 -17605 -14.56%
9 Ameriprise Financial Inc $1084360 101342 +101342 NEW BUY
10 Morgan Stanley $848366 79286 -44826 -36.12%
11 Invesco Ltd. $765724 71563 +71563 NEW BUY
12 Principal Financial Group Inc $682735 63807 +4213 +7.07%
13 Barclays Plc $531832 49704 +26547 +114.64%
14 Bank Of America Corp /De/ $334161 31230 -22424 -41.79%
15 Jpmorgan Chase & Co $159841 14624 -23056 -61.19%
16 American Financial Group Inc $108124 10105 Held
17 Citigroup Inc $96461 9015 +1906 +26.81%
18 Royal Bank Of Canada $34000 3174 -1693 -34.79%
19 Pnc Financial Services Group, Inc. $10689 999 +650 +186.25%
20 Amalgamated Financial Corp. $138 2542 +2542 NEW BUY
21 Us Bancorp \De\ $107 10 -25 -71.43%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.